Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer

NCT06079242 is registered in ClinicalTrials.gov with GrandPharma (China) Co., Ltd. as lead sponsor.

NCT NCT06079242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06079242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer
Lead sponsor
GrandPharma (China) Co., Ltd.
Phase
Observational
Overall status
Not yet recruiting
Start date
October 15, 2023
Completion date
April 1, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms